Julien Ablain

2.6k total citations
29 papers, 1.6k citations indexed

About

Julien Ablain is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Julien Ablain has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Hematology and 9 papers in Cell Biology. Recurrent topics in Julien Ablain's work include Retinoids in leukemia and cellular processes (11 papers), Acute Myeloid Leukemia Research (10 papers) and Zebrafish Biomedical Research Applications (7 papers). Julien Ablain is often cited by papers focused on Retinoids in leukemia and cellular processes (11 papers), Acute Myeloid Leukemia Research (10 papers) and Zebrafish Biomedical Research Applications (7 papers). Julien Ablain collaborates with scholars based in France, United States and Lebanon. Julien Ablain's co-authors include Leonard I. Zon, Hugues de Thé, Song Yang, Ellen M. Durand, Yi Zhou, David M. Langenau, Chuan Yan, Maurizio Fazio, Aurélien de Reyniès and Kim L. Rice and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Julien Ablain

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julien Ablain France 18 1.2k 433 338 292 271 29 1.6k
Anthony Boureux France 16 1.2k 1.0× 219 0.5× 370 1.1× 236 0.8× 499 1.8× 25 1.9k
Yinyin Huang United States 17 1.4k 1.1× 149 0.3× 286 0.8× 166 0.6× 529 2.0× 36 1.8k
Song Yang United States 16 855 0.7× 383 0.9× 163 0.5× 305 1.0× 110 0.4× 44 1.4k
Michael Oelgeschläger Germany 23 2.2k 1.9× 314 0.7× 137 0.4× 237 0.8× 213 0.8× 47 2.8k
Olivier Albagli France 26 1.7k 1.4× 180 0.4× 291 0.9× 486 1.7× 361 1.3× 60 2.6k
J. Ng United States 21 850 0.7× 475 1.1× 182 0.5× 764 2.6× 268 1.0× 72 2.0k
Masato Umikawa Japan 19 1.3k 1.1× 683 1.6× 149 0.4× 210 0.7× 141 0.5× 24 1.9k
M. Dolores Delgado Spain 31 2.1k 1.8× 152 0.4× 411 1.2× 262 0.9× 616 2.3× 68 2.8k
Niels H. Gehring Germany 39 3.6k 3.0× 192 0.4× 229 0.7× 209 0.7× 150 0.6× 68 4.2k
Susheela Dhut United Kingdom 18 1.3k 1.1× 413 1.0× 231 0.7× 92 0.3× 184 0.7× 31 1.6k

Countries citing papers authored by Julien Ablain

Since Specialization
Citations

This map shows the geographic impact of Julien Ablain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Ablain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Ablain more than expected).

Fields of papers citing papers by Julien Ablain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Ablain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Ablain. The network helps show where Julien Ablain may publish in the future.

Co-authorship network of co-authors of Julien Ablain

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Ablain. A scholar is included among the top collaborators of Julien Ablain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Ablain. Julien Ablain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ablain, Julien, et al.. (2023). Nonepithelial cancer dissemination: specificities and challenges. Trends in cancer. 10(4). 356–368. 1 indexed citations
2.
Ablain, Julien, Julien Jacquemetton, Elisabetta Marangoni, et al.. (2023). PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer. Life Science Alliance. 6(10). e202302009–e202302009. 8 indexed citations
3.
Ablain, Julien, Harriet Rothschild, Song Yang, et al.. (2022). Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion. Nature Genetics. 54(12). 1839–1852. 10 indexed citations
4.
Fazio, Maurizio, Ellen van Rooijen, Michelle Dang, et al.. (2021). SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance. eLife. 10. 9 indexed citations
5.
Fazio, Maurizio, Julien Ablain, Chuan Yan, David M. Langenau, & Leonard I. Zon. (2020). Zebrafish patient avatars in cancer biology and precision cancer therapy. Nature reviews. Cancer. 20(5). 263–273. 148 indexed citations
6.
Ablain, Julien, Sixue Liu, Gatien Moriceau, Roger S. Lo, & Leonard I. Zon. (2020). SPRED1 deletion confers resistance to MAPK inhibition in melanoma. The Journal of Experimental Medicine. 218(3). 21 indexed citations
7.
Ablain, Julien, Mengshu Xu, Harriet Rothschild, et al.. (2018). Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science. 362(6418). 1055–1060. 97 indexed citations
8.
McConnell, Alicia M., Jeffrey K. Mito, Julien Ablain, et al.. (2018). Neural crest state activation in NRAS driven melanoma, but not in NRAS-driven melanocyte expansion. Developmental Biology. 449(2). 107–114. 16 indexed citations
9.
Kaufman, Charles K., Christian Mosimann, Zi Peng Fan, et al.. (2016). A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science. 351(6272). aad2197–aad2197. 267 indexed citations
10.
Ablain, Julien & Leonard I. Zon. (2016). Tissue-specific gene targeting using CRISPR/Cas9. Methods in cell biology. 135. 189–202. 19 indexed citations
11.
Ablain, Julien, Brigitte Poirot, Cécile Esnault, Jacqueline Lehmann‐Che, & Hugues de Thé. (2015). p53 as an Effector or Inhibitor of Therapy Response. Cold Spring Harbor Perspectives in Medicine. 6(1). a026260–a026260. 10 indexed citations
12.
Ablain, Julien, Ellen M. Durand, Song Yang, Yi Zhou, & Leonard I. Zon. (2015). A CRISPR/Cas9 Vector System for Tissue-Specific Gene Disruption in Zebrafish. Developmental Cell. 32(6). 756–764. 272 indexed citations
13.
Jing, Lili, Owen J. Tamplin, Michael Chen, et al.. (2015). Adenosine signaling promotes hematopoietic stem and progenitor cell emergence. The Journal of Experimental Medicine. 212(5). 649–663. 69 indexed citations
14.
Bellis, Floriana De, Vincenzo Carafa, Mariarosaria Conte, et al.. (2014). Context-Selective Death of Acute Myeloid Leukemia Cells Triggered by the Novel Hybrid Retinoid-HDAC Inhibitor MC2392. Cancer Research. 74(8). 2328–2339. 27 indexed citations
15.
Ablain, Julien, et al.. (2014). Activation of a promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia cure. Nature Medicine. 20(2). 167–174. 141 indexed citations
16.
Ablain, Julien, Aurélien de Reyniès, Laurent Pérès, et al.. (2014). Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation. Blood. 124(25). 3772–3780. 33 indexed citations
17.
Ablain, Julien & Leonard I. Zon. (2013). Of fish and men: using zebrafish to fight human diseases. Trends in Cell Biology. 23(12). 584–586. 80 indexed citations
18.
Ablain, Julien, et al.. (2013). How animal models of leukaemias have already benefited patients. Molecular Oncology. 7(2). 224–231. 4 indexed citations
19.
Ablain, Julien & Hugues de Thé. (2011). Revisiting the differentiation paradigm in acute promyelocytic leukemia. Blood. 117(22). 5795–5802. 100 indexed citations
20.
Volpato, Milène, Julien Ablain, & Roger M. Phillips. (2008). Inhibition of Lactate Dehydrogenase (LDH-A) potentiates the activity of NQO1 (NAD(P)H:Quinone oxidoreductase-1) by increasing cellular NADH levels.. Cancer Research. 68. 4358–4358. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony Boureux Breakdown of academic impact, for papers by Yinyin Huang Breakdown of academic impact, for papers by Song Yang Breakdown of academic impact, for papers by Michael Oelgeschläger Breakdown of academic impact, for papers by Olivier Albagli Breakdown of academic impact, for papers by J. Ng Breakdown of academic impact, for papers by Masato Umikawa Breakdown of academic impact, for papers by M. Dolores Delgado Breakdown of academic impact, for papers by Niels H. Gehring Breakdown of academic impact, for papers by Susheela Dhut
Rankless by CCL
2026